Inari Medical Inc
NASDAQ:NARI

Watchlist Manager
Inari Medical Inc Logo
Inari Medical Inc
NASDAQ:NARI
Watchlist
Price: 49.66 USD -0.18% Market Closed
Market Cap: 2.9B USD
Have any thoughts about
Inari Medical Inc?
Write Note

Intrinsic Value

The intrinsic value of one NARI stock under the Base Case scenario is 33.36 USD. Compared to the current market price of 49.66 USD, Inari Medical Inc is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NARI Intrinsic Value
33.36 USD
Overvaluation 33%
Intrinsic Value
Price
Base Case Scenario

Valuation Backtest
Inari Medical Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for NARI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about NARI?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Inari Medical Inc

Provide an overview of the primary business activities
of Inari Medical Inc.

What unique competitive advantages
does Inari Medical Inc hold over its rivals?

What risks and challenges
does Inari Medical Inc face in the near future?

Has there been any significant insider trading activity
in Inari Medical Inc recently?

Summarize the latest earnings call
of Inari Medical Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Inari Medical Inc.

Provide P/S
for Inari Medical Inc.

Provide P/E
for Inari Medical Inc.

Provide P/OCF
for Inari Medical Inc.

Provide P/FCFE
for Inari Medical Inc.

Provide P/B
for Inari Medical Inc.

Provide EV/S
for Inari Medical Inc.

Provide EV/GP
for Inari Medical Inc.

Provide EV/EBITDA
for Inari Medical Inc.

Provide EV/EBIT
for Inari Medical Inc.

Provide EV/OCF
for Inari Medical Inc.

Provide EV/FCFF
for Inari Medical Inc.

Provide EV/IC
for Inari Medical Inc.

Show me price targets
for Inari Medical Inc made by professional analysts.

What are the Revenue projections
for Inari Medical Inc?

How accurate were the past Revenue estimates
for Inari Medical Inc?

What are the Net Income projections
for Inari Medical Inc?

How accurate were the past Net Income estimates
for Inari Medical Inc?

What are the EPS projections
for Inari Medical Inc?

How accurate were the past EPS estimates
for Inari Medical Inc?

What are the EBIT projections
for Inari Medical Inc?

How accurate were the past EBIT estimates
for Inari Medical Inc?

Compare the revenue forecasts
for Inari Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Inari Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Inari Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Inari Medical Inc compared to its peers.

Compare the P/E ratios
of Inari Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Inari Medical Inc with its peers.

Analyze the financial leverage
of Inari Medical Inc compared to its main competitors.

Show all profitability ratios
for Inari Medical Inc.

Provide ROE
for Inari Medical Inc.

Provide ROA
for Inari Medical Inc.

Provide ROIC
for Inari Medical Inc.

Provide ROCE
for Inari Medical Inc.

Provide Gross Margin
for Inari Medical Inc.

Provide Operating Margin
for Inari Medical Inc.

Provide Net Margin
for Inari Medical Inc.

Provide FCF Margin
for Inari Medical Inc.

Show all solvency ratios
for Inari Medical Inc.

Provide D/E Ratio
for Inari Medical Inc.

Provide D/A Ratio
for Inari Medical Inc.

Provide Interest Coverage Ratio
for Inari Medical Inc.

Provide Altman Z-Score Ratio
for Inari Medical Inc.

Provide Quick Ratio
for Inari Medical Inc.

Provide Current Ratio
for Inari Medical Inc.

Provide Cash Ratio
for Inari Medical Inc.

What is the historical Revenue growth
over the last 5 years for Inari Medical Inc?

What is the historical Net Income growth
over the last 5 years for Inari Medical Inc?

What is the current Free Cash Flow
of Inari Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Inari Medical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Inari Medical Inc

Current Assets 263.4m
Cash & Short-Term Investments 111.5m
Receivables 84.4m
Other Current Assets 67.4m
Non-Current Assets 433.9m
Long-Term Investments 1.5m
PP&E 72.4m
Intangibles 357.2m
Other Non-Current Assets 2.8m
Current Liabilities 148.8m
Accounts Payable 15.5m
Accrued Liabilities 133.3m
Non-Current Liabilities 113.7m
Other Non-Current Liabilities 113.7m
Efficiency

Earnings Waterfall
Inari Medical Inc

Revenue
574.5m USD
Cost of Revenue
-75.7m USD
Gross Profit
498.8m USD
Operating Expenses
-546.7m USD
Operating Income
-47.9m USD
Other Expenses
-30.6m USD
Net Income
-78.6m USD

Free Cash Flow Analysis
Inari Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

Inari Medical reported third-quarter 2024 revenue of $153.4 million, a 21% increase year-over-year, driven by robust VTE and emerging therapies. International revenue surged 76.4% to $11.5 million. The company raised its full-year revenue guidance to between $601.5 million and $604.5 million, reflecting a growth of 22% to 22.5%. Inari anticipates reaching sustained operating profitability in the first half of 2025, with expected breakeven GAAP operating income in Q4. The upcoming PEERLESS data may unlock a $150 million market opportunity as the company continues to penetrate underdeveloped therapy markets internationally.

What is Earnings Call?
Fundamental Scores

NARI Profitability Score
Profitability Due Diligence

Inari Medical Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
38/100
Profitability
Score

Inari Medical Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

NARI Solvency Score
Solvency Due Diligence

Inari Medical Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
60/100
Solvency
Score

Inari Medical Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NARI Price Targets Summary
Inari Medical Inc

Wall Street analysts forecast NARI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NARI is 65.86 USD with a low forecast of 48.48 USD and a high forecast of 90.3 USD.

Lowest
Price Target
48.48 USD
2% Downside
Average
Price Target
65.86 USD
33% Upside
Highest
Price Target
90.3 USD
82% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for NARI?

Click here to dive deeper.

Dividends

Inari Medical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for NARI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NARI Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

NARI News

Other Videos

Profile

Inari Medical Inc Logo
Inari Medical Inc

Country

United States of America

Industry

Health Care

Market Cap

2.9B USD

Dividend Yield

0%

Description

Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 800 full-time employees. The company went IPO on 2020-05-22. The firm operates through the development and commercialization of invasive mechanical thrombectomy devices to treat thromboembolism in the venous system. Its product offerings consist of two minimally invasive, catheter-based mechanical thrombectomy systems, which are for venous system and the treatment of the two distinct manifestations of venous thromboembolism (VTE), deep vein thrombosis (DVT), and pulmonary embolism (PE). The Company’s products include ClotTriever System, FlowTriever System, FlowSaver, FlowStasis and FlowTriever 2. The ClotTriever system is a mechanical thrombectomy system designed to core, capture and remove large clots from large vessels and is used to treat DVT and its components include ClotTriever Catheter and ClotTriever Sheath. The FlowTriever is a large bore catheter-based aspiration and mechanical thrombectomy system designed to remove large clots from large vessels to treat PE.

Contact

CALIFORNIA
Irvine
6001 Oak Canyon, Suite 100, Suite 100
+19499234747.0
www.inarimedical.com

IPO

2020-05-22

Employees

800

Officers

CEO, President & Director
Mr. Andrew J. Hykes
Chief Medical Officer
Dr. Thomas M. Tu M.D.
Senior Vice President of Operations
Mr. Paul A. Koehn
Vice President of Investor Relations
Mr. John Hsu C.F.A.
General Counsel & Secretary
Ms. Angela Ahmad
Senior Vice President of Marketing
Mr. Eric Khairy
Show More
Senior VP of Sales & Senior VP of U.S. Sales
Mr. Tim A. Benner
Senior VP & GM of LimFlow
Ms. Tara Dunn
Senior Vice President of Engineering
Mr. Brian Strauss
Chief Medical Officer of LimFlow
Dr. Shon Chakrabarti M.D., M.P.H.
Show Less

See Also

Discover More
What is the Intrinsic Value of one NARI stock?

The intrinsic value of one NARI stock under the Base Case scenario is 33.36 USD.

Is NARI stock undervalued or overvalued?

Compared to the current market price of 49.66 USD, Inari Medical Inc is Overvalued by 33%.

Back to Top